Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies.
Document Type
Article
Publication Title
Current treatment options in cardiovascular medicine
Abstract
PURPOSE OF REVIEW: This review explores key features and potential management controversies in two emerging populations in heart failure: heart failure with recovered ejection fraction (HF-recovered EF) and heart failure with mid-range ejection fraction (HFmrEF).
RECENT FINDINGS: While HF-recovered EF patients have better outcomes than heart failure with reduced ejection fraction (HFrEF), they continue to have symptoms, persistent biomarker elevations, and abnormal outcomes suggesting a continued disease process. HFmrEF patients appear to have features of HFrEF and heart failure with preserved ejection fraction (HFpEF), but have a high prevalence of ischemic heart disease and may represent a transitory phase between the HFrEF and HFpEF. Management strategies have insufficient data to warrant standardization at this time. HF-recovered EF and HFmrEF represent new populations with unmet needs and expose the pitfalls of an EF basis for heart failure classification.
First Page
35
Last Page
35
DOI
10.1007/s11936-018-0628-9
Publication Date
4-3-2018
Recommended Citation
Unkovic P, Basuray A. Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies. Curr Treat Options Cardiovasc Med. 2018 Apr 3;20(4):35. doi: 10.1007/s11936-018-0628-9. PMID: 29616374.